Corcept Therapeutics Incorporated (NASDAQ:CORT) stock observed trading -38.22% off 52-week high price. On the other end, the stock has been noted 13.09% away from low price over the last 52-weeks. The stock disclosed a move of -15.41% away from 50 day moving average and -15.00% away from 200 day moving average. Moving closer, we can see that shares have been trading -14.70% off 20-day moving average. It has market cap of $1.29B.

On March 12, 2020, Corcept Therapeutics Incorporated (NASDAQ:CORT) a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, disclosed that former Gilead Sciences executive Gregg Alton has joined Corcept’s Board of Directors. Mr. Alton has also been appointed as Chair of the Corporate Governance and Nominating Committee of the Board of Directors.

Mr. Alton served as Gilead’s interim Chief Executive Officer from January 2019 until March 2019. Before that, he was Gilead’s Chief Patient Officer, responsible for Gilead’s government affairs, public affairs, patient outreach and engagement initiatives, as well as efforts to facilitate access to its medicines around the world. Mr. Alton also oversaw Gilead’s corporate and medical affairs functions, its digital patient solutions and patient-centered outcomes groups, and commercial operations in certain countries. He had previously served as Gilead’s General Counsel.

I am excited to welcome Gregg to our Board, said Joseph K. Belanoff, MD, Corcept’s Chief Executive Officer. His twenty years of experience and broad portfolio of responsibilities at Gilead will be invaluable as our commercial operations mature and we advance our proprietary selective cortisol modulators in a wide range of serious disorders. Gregg has devoted his career to helping patients and physicians understand their treatment options and obtain access to life-saving medications.

The USA based company Corcept Therapeutics Incorporated moved with change of 3.05% to $10.8 with the total traded volume of 1257433 shares in recent session versus to an average volume of 938.47K shares. The stock was observed in the 5 days activity at -6.57%. The one month performance of stock was -20.24%. CORT’s shares are at -20.41% for the quarter and driving a -11.33% return over the course of the past year and is now at -10.74% since this point in 2018.  Right now the stock beta is 1.39. The average volatility for the week and month was at 8.74% and 6.20% respectively. There are 119.73M shares outstanding and 103.14M shares are floated in market.